Are oldest old patients with diffuse large B-cell lymphoma different than their younger counterparts: Results from the REALYSA real-life cohort
As the fastest-growing age group in developed countries, the oldest old require a special attention and further work on this population is needed.
Authors
- Sandra Le Guyader Peyrou
- Angéline Galvin (ORCID: https://orcid.org/0000-0001-9957-5418)
- Alexandre Bélot (ORCID: https://orcid.org/0000-0003-4902-5332)
- Pierre Soubeyran (ORCID: https://orcid.org/0000-0003-3244-7299)
- Fontanet Bijou (ORCID: https://orcid.org/0000-0001-6768-7175)
- Cédric Rossi (ORCID: https://orcid.org/0000-0003-3717-7961)
- C. Cantrelle (ORCID: https://orcid.org/0000-0002-3737-1126)
- Hadia Khebbeb Hafirassou
- Loïc Ysebaert (ORCID: https://orcid.org/0000-0001-8478-5623)
- Alain Monnereau (ORCID: https://orcid.org/0000-0002-5056-1397)
- Hervé Ghesquières
- Ludovic Fouillet (ORCID: https://orcid.org/0009-0007-3281-5043)
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Institut universitaire du cancer de Toulouse Oncopole (FR)
- Hospices Civils de Lyon (FR)
- Bordeaux Population Health (FR)
- The Lymphoma Academic Research Organisation (FR)
- Institute Cancer De La Loire Lucien Neuwirth (FR)
- Hôpital Lyon Sud (FR)
- Institut Bergonié (FR)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1016/j.canep.2025.102812
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Amgen
- Bristol-Myers Squibb
- AstraZeneca
- Celgene
- Institut National de la Santé et de la Recherche Médicale
- Ligue Contre le Cancer
- Hospices Civils de Lyon